logo

For the Inventor, By the Inventor

Boston, MA, United States of America

Ziopharm Oncology, Inc.

Calculating rank
USPTO Granted Patents = 12

% Expired Patents = 75.0


Trademarks = 7

Forward Citations = 15

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal John C Amedio, Jr (5 out of 9 patents)

silverMedal Philip B Komarnitsky (4 out of 8 patents)

bronzeMedal Barbara P Wallner (4 out of 34 patents)

4.  Frank Walter Waligora (3 out of 4 patents)

5.  Brian Renzelmann (2 out of 3 patents)

6.  Paul Gutsch (2 out of 3 patents)

7.  Lee Roy Morgan (1 out of 20 patents)

8.  Thomas Beckers (1 out of 36 patents)

9.  Jürgen Engel (1 out of 10 patents)

10.  Gerald Bacher (1 out of 6 patents)

11.  Robert Peter Gale (1 out of 1 patent)

12.  Bernd Nickel (1 out of 27 patents)

13.  Peter Emig (1 out of 29 patents)

14.  Thomas Klenner (1 out of 11 patents)

15.  Erik Bruyneel (1 out of 2 patents)


12 patents:

1. 9346836 - Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents (2016-05-24),
2. 9340563 - Salts of isophosphoramide mustard and analogs thereof (2016-05-17),
3. 9254298 - Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof (2016-02-09),
4. 9145431 - Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof (2015-09-29),
5. 8796329 - Method for controlling angiogenesis in animals (2014-08-05),
6. 8664201 - Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof (2014-03-04),
7. 8604007 - Salts of isophosphoramide mustard and analogs thereof (2013-12-10),
8. 8334398 - Compounds and methods for the treatment of cancer (2012-12-18),
9. 8252773 - Combination therapy with organic arsenicals (2012-08-28),
10. 7968738 - Compounds and methods for the treatment of cancer (2011-06-28),
11. 7964583 - Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents (2011-06-21),
12. 7452910 - Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties (2008-11-18),
Company Overview
Ziopharm Oncology, Inc. is a biotechnology company based in Boston, MA, focused on the development of innovative cancer therapies. The company specializes in utilizing its proprietary technology platforms to create treatments that harness the body's immune system to target and destroy cancer cells. Ziopharm's research emphasizes the advancement of cellular and gene therapies, aiming to provide effective solutions for patients with various types of cancer. The organization is committed to addressing unmet medical needs through its cutting-edge research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#170 in Boston, MA

#1,549 in Massachusetts

#25,589 in US

#48,235 in the World

Boston, MA (US)
Boston, MA, United States of America

Ziopharm Oncology, Inc.

Forward Citations = 15

17 inventors:

goldMedal John C Amedio, Jr (5 out of 9 patents)

silverMedal Philip B Komarnitsky (4 out of 8 patents)

bronzeMedal Barbara P Wallner (4 out of 34 patents)

4.  Frank Walter Waligora (3 out of 4 patents)

5.  Brian Renzelmann (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ziopharm Oncology, Inc.. Retrieved from https://idiyas.com/company/ziopharm-oncology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…